Bridging the Gap in Lung Cancer: Novel Biomarkers, Metabolic Drivers, and Advanced Therapeutics from Bench to Bedside

Biomedicines · Published 2026-07-27 · DOI 10.3390/biomedicines14081681

Free full text

Authors (2)

Jeongmi Lee, Seung Hyeun Lee

Abstract

The therapeutic paradigms for both non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) have entered an unprecedented era of precision oncology, a transformative evolution fundamentally driven by the seamless integration of translational science [...]

Abstract from DOAJ. Public domain (CC0 1.0).

Read the article at the publisher →

Publication details

Year

2026

Citation

Lee, J., Lee, S. (2026). Bridging the Gap in Lung Cancer: Novel Biomarkers, Metabolic Drivers, and Advanced Therapeutics from Bench to Bedside. Biomedicines. https://doi.org/10.3390/biomedicines14081681

Related articles

• First-line single-agent pembrolizumab for PD-L1-positive (tumor proportion score ≥ 50%) advanced non-small cell lung cancer in the real world: impact in brain metastasis: a national French multicentric cohort (ESCKEYP GFPC study) · Cancer Immunology, Immunotherapy · 2023 · Cites or is cited by this article
• Lipoprotein(a) as a Cardiovascular Risk Factor: Clinical Significance and Therapeutic Perspectives · Biomedicines · 2026 · Same journal
• Advancing Human Placental Modeling Through Stem-Cell-Derived Trophoblast Organoids and Reprogramming Innovations · Biomedicines · 2026 · Same journal
• The Role of Endothelial–Mesenchymal Transition (EndMT) in Aneurysm Formation · Biomedicines · 2026 · Same journal
• Ectoine Inhibits IL-1β-Induced Inflammation by Suppressing the NF-κB Pathway in Chondrocytes and Alleviates Osteoarthritis in a Rat Model · Biomedicines · 2026 · Same journal
• Differential Protective Actions of Dulaglutide and Dexamethasone in Methotrexate Induced Pulmonary Fibrosis: Relationship with AMPK and Beclin-1 Levels · Biomedicines · 2026 · Same journal
• Evolving Landscape of Systemic Therapy for Hepatocellular Carcinoma: From Targeted Therapy and Combination Strategies to Emerging Therapies · Biomedicines · 2026 · Same journal
• Evaluation of Early and Delayed Meloxicam Treatment Against Regulated Cell Death Pathways and ERK1/2 Phosphorylation in a Rat Model of Renal Ischemia–Reperfusion Injury · Biomedicines · 2026 · Same journal
• Overcoming mTOR Inhibitor Resistance: From Biological Basis to Therapeutic Strategies · Biomedicines · 2026 · Same journal
• Region-Specific Proteomic Profiles of Extracellular Vesicles (EVs) Derived from Human Macular and Peripheral RPE-Choroid Explants · Biomedicines · 2026 · Same journal